Predictive Factors and Autonomy Level Change
Recruiting · NCT02302482 · Interventional (participants receive a specific treatment) · Lead sponsor: Hospices Civils de Lyon
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The investigators aimed at developing a database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative personal and with the University hospital computer science department. The main objective is to study the predictive factors associated with the change of functional autonomy level, measured every 6 months to 12 months by phone, in a Memory Clinic. The study population would consist in about 1000 patients with ADRD. The length of follow-up of each patient will be 3 years.
Who can take part
Inclusion criteria
- Patients who undergo a medical visit in the Memory Clinic for the 1st time
- Patients living at home or in housing
- Patients with memory impairment, at all stage of the disease
Exclusion criteria
- Patients in institution
- Patients under legal protection
- Patients with a hearing or visual impairment, which dot not allow to carry out the examination
Where it is running
2 locations listed.
- Hôpital Dugoujon - Caluire-et-Cuire, France
- Hospices Civils de Lyon - Hôpital des Charpennes - Lyon, France